MedTrace Logo

Booster Dose of HCG for Unruptured Follicle in Non IVF/ICSI Cycles

NCT03580031 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2022-02-21

No results posted yet for this study

Summary

This study will be conducted to assess the effect of booster dose of hCG on the unruptured follicles in non IVF/ICSI cycles.

Conditions

  • LUF - Luteinised Unruptured Follicle Syndrome

Interventions

DRUG

hCG

A booster dose (10,000 IU of hCG) was given IM 48 hours after first triggering dose

DRUG

Saline Solution

2 ml of normal saline will be injected 48 hours after first triggering dose

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Ayman Dawood, MD · Lecturer at Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-01
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03580031 on ClinicalTrials.gov